RAIS reveals information on global inequality of allocation and provision of the COVID-19 vaccine and six observations
Today (February 20), Professor Dr. Sirirerk Songsivilai, Permanent Secretary of the Ministry of Higher Education, Science, Research and Innovation (EW) reports the situation of the COVID-19 vaccine supply. By analyzing the economic status of countries around the world, it was found that “there is clear inequality. More than 50% of vaccine reservations are among high-income countries, accounting for only 16% of the global population. But the vaccine has been reserved more than the population. This will change the way the excess vaccine is distributed to more countries.
Globally, there are over 200 million doses of -19 vaccines, with the United States having the most 55.2 million doses, China is second with 40.5 million doses, and when considering the population share, Israel is found. Vaccine already in 80% of the population
Important information about this week’s COVID vaccine. Summarized as follows
1. Rich countries get more vaccines than poor countries.
There are disparities in access to vaccines. The number of vaccine reservations for each country differs between high-income countries and low-income countries. More than 50% of the COVID-19 vaccine is reserved by high-income countries, which account for just 16% of the global population.
2. Many countries reserve more vaccines than their population.
Many high-income countries reserve more vaccines than their own population. This was in part because they were unsure of which vaccines would be highly effective or safe. Including management of vaccine delivery periods
– Canada has reserved the vaccine 9.2 times the population.
– UK: 6.1 times the population
– Australia is 4.9 times the population
– New Zealand is 4.4 times the population
– The United States is 4.3 times the population.
etc.
3. Low- and middle-income countries Access to vaccines by the COVAX Project
The COVAX Project’s COVAX Vaccine Delivery Plan aims to provide and distribute the vaccine equally in high-income countries. Middle income and low income It said it aims to deliver more than 2 billion doses of the vaccine by 2021, with at least 1,800 million doses to be delivered to more than 92 low- and middle-income countries, with the first half of 2021. 145 countries have received the vaccine, covering approximately 3.3% of the population.
4. Many countries adopt diplomatic policies on vaccines.
Countries with a large number of vaccine-producing capacities, such as China, the United Kingdom and Russia, have adopted donation and aid mechanisms to vaccinate countries in diplomatic, international relations and humanitarian terms, such as China has announced guidelines that provide assistance. Important to equal vaccine allocation around the world It has helped donate vaccines made in China to 53 developing countries, including 22 countries, and announced that it would donate 10 million doses to the COVAX project.
5. COVID-19 Vaccine That has been used, is effective, effective and safe
This week, the key findings of a study on the COVID-19 vaccine are:
– effectiveness of the vaccine Can stimulate the immune system well
– effectiveness of the vaccine Can reduce the severity Causing the number of patients and deaths to be reduced clearly
– vaccine safety Used vaccines have relatively few side effects.
– The vaccine can boost immunity quite well after the first shot. It should also be able to increase the time between first and second injections. This reduces the burden of accelerating the second injection. This makes it possible to distribute the existing vaccines to cover a larger population. Instead of speeding up the second dose, the vaccine is administered as a first dose for someone who has not yet been vaccinated. Therefore there will be more people who have already been vaccinated
– Persistence of the Vaccine It was found that the vaccine could be stored and transported at higher temperatures. Reduce restrictions on transportation and distribution of vaccines. Which will allow to accelerate the amount of injection
– There is a concern about the protective effect against the mutant infection. The vaccine has decreased effectiveness against COVID-19. Some species, especially from South Africa
6.Countries where the number of vaccines has been exceeded Will distribute the reserved vaccine to other countries
From the effective use of the vaccine Will make many countries start to feel relieved And may be able to pay off accelerated delivery of excess vaccines This will change international vaccination. Bring vaccines that are not urgent or overbooked. Spread to other countries more
– .
